Literature DB >> 33086102

Drug-Integrating Amphiphilic Nanomaterial Assemblies: 1. Spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils.

Diana Velluto1, Damir Bojadzic2, Teresa De Toni3, Peter Buchwald4, Alice A Tomei5.   

Abstract

Immunomodulatory therapies are limited by unavoidable side effects as well as poor solubility, stability, and pharmacokinetic properties. Nanomaterial-based drug delivery may overcome these limitations by increasing drug solubility, site-targeting, and duration of action. Here, we prepared innovative drug-integrating amphiphilic nanomaterial assemblies (DIANA) with tunable hydrophobicity, size, and morphology, and we evaluated their ability to deliver cyclosporine A (CsA) for immunomodulatory applications. We synthesized amphiphilic block copolymers made of poly(ethylene glycol)-poly(propylene sulfide) (PEG-PPS) and poly(ethylene glycol)-oligo(ethylene sulfide) (PEG-OES) that can self-assemble into solid core nanomicelles (nMIC, with ≈20 nm diameter) and nanofibrils (nFIB, with ≈5 nm diameter and > 500 nm length), respectively. nMIC and nFIB displayed good CsA encapsulation efficiency (up to 4.5 and 2 mg/mL, respectively in aqueous solution), superior to many other solubilization methods, and provided sustained release (>14 and > 7 days for the nMIC and nFIB) without compromising CsA's pharmacological activity. Treatment of insulin-secreting cells with unloaded DIANAs did not impair cell viability and functionality. Both CsA-loaded DIANAs inhibited the proliferation and activation of insulin-reactive cytotoxic T cells in vitro. Subcutaneous injections of CsA-loaded DIANAs in mice provided CsA sustained release, decreasing alloantigen-induced immune responses in the draining lymph node at lower doses and reduced administration frequency than unformulated CsA. While nMIC solubilized higher amounts and provided more sustained release of CsA in vitro, nFIB enhanced cellular uptake and promoted local retention due to slower trafficking in vivo. DIANAs provide a versatile platform for a local immune suppression regimen that can be applied to allogeneic cell transplantation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Block-copolymers; Drug delivery; Immunosuppression; Local immunomodulation; Nanomaterials; Pancreatic islets; Self-assembling

Mesh:

Substances:

Year:  2020        PMID: 33086102      PMCID: PMC7904645          DOI: 10.1016/j.jconrel.2020.10.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  68 in total

Review 1.  Modulation of innate immunity by cyclosporine A.

Authors:  Alex M Liddicoat; Ed C Lavelle
Journal:  Biochem Pharmacol       Date:  2019-03-15       Impact factor: 5.858

Review 2.  Strategies to address low drug solubility in discovery and development.

Authors:  Hywel D Williams; Natalie L Trevaskis; Susan A Charman; Ravi M Shanker; William N Charman; Colin W Pouton; Christopher J H Porter
Journal:  Pharmacol Rev       Date:  2013-01       Impact factor: 25.468

Review 3.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 4.  Mechanisms of action of cyclosporine.

Authors:  S Matsuda; S Koyasu
Journal:  Immunopharmacology       Date:  2000-05

Review 5.  Customized PEG-derived copolymers for tissue-engineering applications.

Authors:  Joerg K Tessmar; Achim M Göpferich
Journal:  Macromol Biosci       Date:  2007-01-05       Impact factor: 4.979

6.  Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.

Authors:  N el Tayar; A E Mark; P Vallat; R M Brunne; B Testa; W F van Gunsteren
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

7.  3D-Printed Drug/Cell Carrier Enabling Effective Release of Cyclosporin A for Xenogeneic Cell-Based Therapy.

Authors:  Tae-Ha Song; Jinah Jang; Yeong-Jin Choi; Jin-Hyung Shim; Dong-Woo Cho
Journal:  Cell Transplant       Date:  2015-01-20       Impact factor: 4.064

8.  PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery.

Authors:  Simona Cerritelli; Diana Velluto; Jeffrey A Hubbell
Journal:  Biomacromolecules       Date:  2007-05-12       Impact factor: 6.988

9.  Aggregation behavior of poly(ethylene glycol-bl-propylene sulfide) di- and triblock copolymers in aqueous solution.

Authors:  Simona Cerritelli; Conlin P O'Neil; Diana Velluto; Antonella Fontana; Marc Adrian; Jacques Dubochet; Jeffrey A Hubbell
Journal:  Langmuir       Date:  2009-10-06       Impact factor: 3.882

10.  MerTK regulates thymic selection of autoreactive T cells.

Authors:  Mark A Wallet; Rafael R Flores; Yaming Wang; Zuoan Yi; Charles J Kroger; Clayton E Mathews; H Shelton Earp; Glenn Matsushima; Bo Wang; Roland Tisch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

View more
  4 in total

1.  Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates.

Authors:  Aaron A Stock; Grisell C Gonzalez; Sophia I Pete; Teresa De Toni; Dora M Berman; Alexander Rabassa; Waldo Diaz; James C Geary; Melissa Willman; Joy M Jackson; Noa H DeHaseth; Noel M Ziebarth; Anthony R Hogan; Camillo Ricordi; Norma S Kenyon; Alice A Tomei
Journal:  Sci Adv       Date:  2022-06-29       Impact factor: 14.957

2.  Parallel Evaluation of Polyethylene Glycol Conformal Coating and Alginate Microencapsulation as Immunoisolation Strategies for Pancreatic Islet Transplantation.

Authors:  Teresa De Toni; Aaron A Stock; Floriane Devaux; Grisell C Gonzalez; Kailyn Nunez; Jessica C Rubanich; Susan A Safley; Collin J Weber; Noel M Ziebarth; Peter Buchwald; Alice A Tomei
Journal:  Front Bioeng Biotechnol       Date:  2022-05-16

Review 3.  Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.

Authors:  Magdalena M Samojlik; Cherie L Stabler
Journal:  Acta Biomater       Date:  2021-06-05       Impact factor: 10.633

4.  Design of an L-Valine-Modified Nanomicelle-Based Drug Delivery System for Overcoming Ocular Surface Barriers.

Authors:  Huimin Wu; Yuchen Xu; Mengru Cai; Longtai You; Jing Liu; Xiaoxv Dong; Xingbin Yin; Jian Ni; Changhai Qu
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.